|
Characteristics
|
Value
|
|---|
|
Gender(male/female)
|
11/12
|
|
Age of onset, y
|
50.4 ± 8.5
|
|
Duration, y
|
11.3 ± 5.8
|
|
Age of surgery, y
|
61.7 ± 8.3
|
|
H&Y stage (off-med)
|
|
Mild(<3)
|
9 (39.1%)
|
|
Severe(≥3)
|
14 (60.9%)
|
|
Levodopa responsiveness, %
|
62.5 ± 19.3
|
|
LEDD, mg/d
|
999.3 ± 516.7
|
|
Dyskinesia
|
|
No
|
14 (60.9%)
|
|
Yes
|
9 (39.1%)
|
|
Motor fluctuations duration, y
|
5.4 ± 3.9
|
|
Disease subtype
|
|
LPS
|
12(52.2%)
|
|
PIGD
|
11 (47.8%)
|
|
Baseline UPDRSIII scores (off-med)
|
50.2 ± 18.2
|
- Data are expressed as numbers, with percentages in parentheses, or as means ± SE. PIGD posture instability and gait difficulty, LPS Limb-predominant symptoms; Baseline refers to “off-medication” state
